IRUBIS
Key Facts
| Invested since | 2022 |
| Based in | München |
About the company
IRUBIS GmbH is a Munich-based startup founded by Anja Müller, Alexander Geißler and Lorenz Sykora-Mirle in 2017. IRUBIS has developed Monipa to bring biological drugs faster to the market. This process analytical technology improves process development and manufacturing of biopharmaceuticals. Monipa is a mid-infrared spectrometer system that enables real-time monitoring and control of important parameters in bioprocessing. It’s single-use interface and the simplifying calibration model, revolutionizes the bioprocess industry. Monipa is already in use by key opinion leaders in the biopharma industry.
Do you want to
know more about this company?
IRUBIS in the news
zum Artikel
Acceleration of Bioprocess Development: IRUBIS secures Pre-Series A Funding led by BioProcess360 Partners
zum Artikel